Wednesday, June 3, 2026

#cancer treatment

2 articles

AI-Designed Cancer Drug BD200 Defeats Resistant Tumors, Outperforms Marketed Antibodies

AI-Designed Cancer Drug BD200 Defeats Resistant Tumors, Outperforms Marketed Antibodies

Salvado•Apr 19, 2026

FDA Fast-Tracks Lung Cancer Drug as Biotech Sector Logs $430M in Deals

FDA Fast-Tracks Lung Cancer Drug as Biotech Sector Logs $430M in Deals

Salvado•Apr 16, 2026